Shelf life – Page 25

How to Use Regression Analysis in Stability OOT Investigations

Addressing OOT and OOS Results in Stability Studies through Regression Analysis In the pharmaceutical and biopharmaceutical sectors, Out of Trend (OOT) and Out of Specification (OOS) findings during stability studies…

How to Set Alert and Action Limits for Stability Trending

Establishing Alert and Action Limits for Effective Stability Trending In pharmaceutical manufacturing, ensuring the stability of products is critical for regulatory compliance and patient safety. Stability trending and statistical analysis…

How to Set Alert and Action Limits for Stability Trending

Implementing Alert and Action Limits in Stability Trending In the realm of pharmaceutical manufacturing, effective stability trending and statistical analysis are essential to validate product shelf-life and ensure regulatory compliance.…

Stability OOT Result After Packaging Site Change: CAPA Strategy

Addressing OOT and OOS Observations After a Change in Packaging Site The pharmaceutical industry often experiences deviations from expected outcomes in stability studies, particularly when changes such as a new…

Stability OOT Result After Packaging Site Change: CAPA Strategy

Addressing Stability Out-of-Trend Results Following Packaging Site Changes In the pharmaceutical manufacturing sector, changes in packaging sites are crucial yet complex, often leading to unexpected stability issues such as Out-of-Trend…

Statistical Analysis of Stability Excursion Impact Using MKT Concepts

Understanding the Impact of Stability Excursions through Statistical Analysis In pharmaceutical manufacturing, stability excursions can significantly impact product quality and regulatory compliance. A stability excursion may manifest as unexpected shifts…

How to Perform Batch Impact Assessment for Stability OOS Results

Effective Strategies for Assessing the Impact of OOS Results in Stability Studies In the realm of pharmaceutical manufacturing and quality assurance, the occurrence of Out-of-Specification (OOS) results during stability studies…

How to Trend pH Drift and Assay Loss in Liquid Dosage Forms

Effective Techniques for Monitoring pH Drift and Assay Loss in Liquid Pharmaceutical Dosage Forms In the realm of pharmaceutical manufacturing, maintaining the integrity of liquid dosage forms is vital for…

Stability OOT and OOS During Tech Transfer: Risk-Based Handling

Managing OOT and OOS Results During Tech Transfer: A Risk-Based Approach In the dynamic landscape of pharmaceutical manufacturing, encountering Out of Trend (OOT) and Out of Specification (OOS) results during…

Stability Data Visualization Methods for Regulatory Reviewers

Effective Visualization Methods for Stability Data Analysis in Regulatory Environments In pharmaceutical manufacturing, ensuring the stability of products is crucial for regulatory compliance and product efficacy. However, the challenges associated…

Why Poor Chamber Mapping Can Create Stability OOT Signals

Understanding Poor Chamber Mapping and Its Impact on Stability Out-of-Trend Signals In the pharmaceutical manufacturing landscape, stability studies are vital for ensuring a product’s quality over its intended shelf life.…

How to Present Stability Statistical Analysis in CTD Submissions

Effective Presentation of Stability Statistical Analysis in CTD Submissions In the pharmaceutical industry, presenting stability statistical analysis effectively in the Common Technical Document (CTD) submissions is crucial to meet regulatory…